Autopsy report · NCT03208296

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

“Study did not start. Another protocol is being developed. Recruitment on hold.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Suspended: paused, and may or may not restart.
• 24 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Phase

Phase 1, Phase 2

Sponsor

Ascend Biopharmaceuticals Ltd

Sponsor type

Industry

Conditions

Basal Cell Carcinoma in Basal Cell Nevus Syndrome

Interventions

ASN-002

Participants

24 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• The Gene Expression Studies of the Role of Tumor Microenvironments in Tumor Progression
  “the study has stopped due to no recruitment” (83% match in meaning)
• Exercise to Prevent Aromatase Inhibitor Side Effects in Breast Cancer Patients
  “The study was stopped due to recruitment difficulties” (81% match in meaning)
• Timing of VTE Prophylaxis in TBI
  “Recruitment not started due to potential conflicting study at same institution. May renew study in the future.” (81% match in meaning)
• A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)
  “The study was ended due to a lack of recruitment” (80% match in meaning)
• The Effect of Ovamax on Oocyte Quality
  “The study was stopped prematurely due to low recruitment rate” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.